United Laboratories International Holdings Limited (United Lab) disclosed that it repurchased 900,000 ordinary shares on 22 June 2026 through on-market transactions on the Hong Kong Stock Exchange.
• Transaction details – Volume: 900,000 shares (0.05% of the 1.97 billion issued shares before the transaction) – Price range: HK$7.98–HK$8.18 per share – Aggregate consideration: HK$7.27 million
• Outstanding buy-backs pending cancellation Including the latest purchase, a total of 2.25 million shares—acquired on 16, 17, 18 and 22 June—remain to be cancelled. This represents approximately 0.12% of United Lab’s current issued share capital of 1.97 billion shares.
• Capital structure unchanged to date As of the close on 22 June 2026, the company’s issued share count stands at 1,973.03 million, with no treasury shares recorded. The repurchased shares will be removed from the share capital register upon cancellation.
• Repurchase mandate utilisation The board was authorised on 25 June 2025 to repurchase up to 181.70 million shares. To date, 2.25 million shares have been bought back under this mandate, equal to 0.12% of the company’s issued share capital at the mandate date, leaving ample headroom for further repurchases.
• Moratorium on new issuance In accordance with Hong Kong listing rules, United Lab is restricted from issuing new shares or disposing of treasury shares until 22 July 2026, 30 days after the latest repurchase.
The company affirms that all buy-backs complied with the Hong Kong Stock Exchange Main Board Listing Rules and other applicable regulations.
Comments